TMAs containing sections of normal fallopian tube (n = 20), ovarian cystadenomas (n = 9), borderline ovarian tumors (tumors with low malignant potential) (n = 21), and invasive ovarian carcinoma (n = 216) were subjected to IHC analysis of elafin expression (Figure 2). This evidence concerns the gene PI3 and ovarian cystadenoma.